Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.33 USD | -7.08% | -48.02% | -82.58% |
05-10 | Guggenheim Downgrades RAPT Therapeutics to Neutral From Buy | MT |
05-10 | Barclays Downgrades RAPT Therapeutics to Equalweight, Price Target at $4 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-82.58% | 151M | |
+3.91% | 109B | |
+10.87% | 105B | |
+0.23% | 22.25B | |
-13.14% | 22.09B | |
-7.66% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- RAPT Stock
- News RAPT Therapeutics, Inc.
- HC Wainwright Downgrades RAPT Therapeutics to Neutral From Buy